index - Epidemiology in dermatology and evaluation of therapeutics Accéder directement au contenu

DOCUMENTS

84

 

NOTICES

152

 

 

MOTS CLES

Antimicrobiens Bacterial rhinosinusitis CSK tyrosine-protein kinase Burden Immune-related adverse events Epidemiology Dermatology Azathioprine Antibiotic resistance Autoimmunity Placebo Antimicrobial resistance Drug reaction COVID-19 Apremilast Aging BTK protein Anxiété Calcium channel blockers Biosimilar Pharmaceuticals Biomédicaments Biological Therapy Access to care Anti-HCV Direct Acting Antivirals DAA Anxiety Abus d'antibiotiques Atrial fibrillation Autoimmune diseases Quality of life Psoriatic arthritis Auto-immune hepatitis Adalimumab Axial spondyloarthritis Pharmaco-Épidémiologie Alcohol Accelerometer Antibiotic misuse Antibiotics CTLA-4 Vigibase® Ethics Immunotherapy Biomarkers Antimicrobials Anti-TNF Endocrine toxicity Biologic Cardiovascular risk ArtThese Angiotensin-converting enzyme inhibitors Sacroiliitis Cancer Meta-Analysis Biologic drug Pharmacovigilance Amyloidosis Prostate cancer Angiotensin receptor blockers Arrhythmia Pregnancy Atopic dermatitis Méta-Analyse Psoriasis Cardiomyopathy Addiction Spondyloarthritis Biologic therapy Cardiovascular therapy Care pathway Stability Acute Myeloid Leukaemia AML Anticancer drugs Intensive care Albinism Pharmacoepidemiology Primary adrenal insufficiency Ankylosing Apre-milast Alitretinoin Graft-versus-host disease Cardio-oncology Immune checkpoint inhibitors Auto-Diagnostic Ankylosing spondylitis Etanercept Ustekinumab Treatment Biological therapy Drug survival Biologics Management Adverse side effects Sipuleucel-T Arthritis Cardiotoxicity Glucocorticoids Infliximab Adolescent ASDAS Beta-lactam antibiotics

 

 

 

Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379

Adresse

Université Paris-Est Créteil Val de Marne (UPEC)

Campus Centre de Créteil
61 Avenue du Général de Gaulle
94010 Créteil Cedex

Courriel

emilie.sbidian@aphp.fr

Site Internet

 

Rattachement(s)

UFR de Santé

Direction

Émilie SBIDIAN

 

Axe(s) de recherche

 


[legende-image]65[/legende-image] Axe 1 : Comment mieux gérer les patients ayant développé des réactins graves aux médicaments, notamment en leur indiquant comment utiliser correctement les agents


[legende-image]65[/legende-image] Axe 2 : Rechercher les facteurs associés aux effets indesirables et à l'efficacité du médicament

 
 

COLLABORATIONS